Autoimmune haemolytic anaemia crisis
Acute haemolysis · Haematology / Oncology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Antibody-mediated red-cell destruction causing rapid anaemia, jaundice and dark urine, classified warm or cold by the antibody. Steroids (warm type) or keeping the patient warm (cold type), with cautious transfusion, are key.
Assessment
Investigations
- FBC + film (spherocytes/agglutination), reticulocytes
- Haemolysis screen (LDH, haptoglobin, bilirubin) and direct antiglobulin test (DAT)
- Classify warm vs cold; look for a trigger (infection, drug, lymphoma)
Management
- Warm AIHA: high-dose corticosteroids (then rituximab/immunosuppression)
- Cold AIHA: keep the patient and all fluids/blood WARM; avoid cold exposure; treat cause
- Transfuse cautiously for symptomatic anaemia (cross-match may be difficult - involve the lab)
- Folic acid; treat the underlying trigger
- Haematology involvement
Drugs & doses
Corticosteroids (warm type)
Keep warm (cold type)
Cautious transfusion
Folic acid
Disposition
Haematology.
Classify the haemolysis as warm or cold - warm gets steroids, cold gets kept warm; and transfuse cautiously after warning the lab about cross-match difficulty.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.